Loss of Frrs1l disrupts synaptic AMPA receptor function, and results in neurodevelopmental, motor, cognitive and electrographical abnormalities. (2019)

First Author: Stewart M
Attributed to:  Gene therapy for refractory epilepsy funded by MRC


No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1242/dmm.036806

PubMed Identifier: 30692144

Publication URI: http://europepmc.org/abstract/MED/30692144

Type: Journal Article/Review

Volume: 12

Parent Publication: Disease models & mechanisms

Issue: 2

ISSN: 1754-8403